| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $24.81M | $26.35M | $31.48M | $36.06M | $36.19M |
| R&D | $15.89M | $18.16M | $22.47M | $25.36M | $23.11M |
| SG&A | $8.92M | $8.19M | $9.00M | $10.71M | $13.09M |
| Operating Income | -$24.81M | -$26.35M | -$31.48M | -$36.06M | -$36.19M |
| Interest Expense | $649.00K | $745.67K | $675.42K | $1.08M | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$25.41M | -$27.58M | -$32.19M | -$36.70M | -$36.36M |
| EPS (basic) | – | – | – | -0.8700 | -0.9000 |
| EPS (diluted) | -6.2700 | -0.5100 | -0.7300 | -0.8700 | -0.9300 |
| Shares (diluted) | $4.06M | $54.04M | $44.48M | $43.15M | $40.69M |